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Systolic inter-arm difference in blood pressure (IAD) and cognitive decline are both 
associated with cardiovascular disease. We hypothesised that IAD may, therefore, be 
predictive of cognitive decline.
Aim
To examine associations of IAD with cognitive decline in a community population.
Design and Setting
Prospective study of older Italian adults enrolled in the InCHIANTI study.
Method
We explored univariable and multivariable associations of IAD with declines in Mini Mental 
State Examination (MMSE) scores, Trail Making Test A and B scores, and a composite 
outcome representing substantial decline in any of these scores. We used backward 
stepwise regression to adjust observed associations of IAD with cognitive decline.
 
Results
The rate of decline for MMSE scores in 1133 participants was greater with systolic IAD ≥ 
5mmHg or ≥ 10mmHg. On univariable analyses continuous IAD was associated with the 
composite outcome (Odds ratio (OR) 1.16 per 5 mmHg of IAD (95%CI 1.02 to 1.31)). 
Substantial decline in MMSE score was seen with IAD ≥5mmHg (OR 1.41 (1.03 to 1.93)), and 
in the composite outcome with IAD ≥5mmHg (OR 1.44 (1.10 to 1.89)) or ≥10mmHg (OR 1.39 
(1.03 to 1.88)). After multivariable adjustment an IAD ≥5mmHg remained associated with 
reductions in the composite outcome, reflecting declining cognitive performance (OR 1.46 
(1.05 to 2.03).
Conclusion
A systolic IAD ≥5mmHg is associated with cognitive decline in a representative older 
population. Given that inter-arm differences in blood pressure are easily measured, 
confirmation of these findings could inform individualised treatment for the prevention of 
cognitive decline and dementia.
250 words
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How this fits in
 Inter-arm blood pressure differences are associated with increased cardiovascular 
and all-cause mortality.
 Cognitive decline is associated with hypertension and cerebrovascular disease, and 
may be mitigated by aggressive blood pressure lowering in those most at risk.
 Detection of an inter-arm difference in blood pressure may identify individuals at 
excess risk of cognitive decline.
 Recognition of IAD as a risk marker for cognitive decline may help to inform 
personalised discussion of blood pressure lowering, and other preventative 
strategies, in reducing the risk of cognitive decline.
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Introduction
Hypertension and dementia are both associated with older age and with each other.1 
Globally the numbers living with dementia are predicted to rise, representing substantial 
and increasing costs and care burdens for society.2 3 Risks of developing dementia are 
associated with known risk markers for cardiovascular disease such as mid-life 
hypertension,4 5 diabetes,6 and a widening pulse pressure.7 
A difference in systolic blood pressures between arms (inter-arm difference; IAD) has also 
been shown to be associated with increased risk of cardiovascular morbidity and mortality, 
and is associated with increasing pulse pressure and arterial stiffness.8 9  A systolic IAD ≥ 
10mmHg is found in 11% of people with hypertension and  7% of those with diabetes.10 The 
precise aetiology of an IAD is incompletely established, however arterial changes seem to be 
a common contributor.11 A body of evidence now exists to support recognition of IAD as an 
early marker for subsequent vascular disease, and to quantify that risk for cardiovascular 
events.12 13
 
Pre-clinical vascular damage can be observed early in the course of hypertension,14 whereas 
measurable cognitive decline or a diagnosis of dementia are later consequences of exposure 
to raised blood pressure.5 15 White matter lesions predict onset of dementia;16 their 
progression is slowed when hypertension is controlled, and antihypertensive treatment is 
associated with reduced risk of subsequent Alzheimer’s disease.17 18 Recent evidence 
suggests that intensive blood pressure lowering may prevent progression of cognitive 
impairment.19 Prediction of those most at risk of future progression of white matter lesions 
and cognitive decline is, therefore,  desirable in order to target or intensify treatment for 
them appropriately.20
Given the above, we considered that IAD may also have a prognostic association with future 
cognitive decline. To our knowledge this association has only to date been reported for a 
sub-group of the Framingham cohort who possess the apolipoprotein E (APOE) ε4 allele, and 
not observed for the overall study population.21 If adults with an IAD are shown to be at risk 
of greater cognitive decline than those without, then IAD measurement in clinical practice 
could help to differentiate those people with most to gain from early interventions and 
intensive blood pressure lowering. We undertook the analyses presented here, using data 
from the InCHIANTI study, a well-documented prospective cohort study of older community 
living adults, to explore the associations of IAD with cognitive decline.22
Page 4 of 23
https://mc04.manuscriptcentral.com/bjgp


































































The Invecchiare in Chianti (InCHIANTI) study is a population-based cohort study of older 
adults based in Greve in Chianti and Bagno a Ripoli in Italy. In total, 1270 participants over 
the age of 65 were recruited from a random sample of city registers between August 1998 
and March 2000. Recruitment was designed to be representative of the older Chianti 
population, with oversampling of those aged over 90 to ensure representation of the oldest 
old within the cohort. Finally, 30 men and women for each decade of age from 20 years 
upwards were also recruited to achieve a total of 1,453. Follow-up has been carried out 
every 3 years for up to 13 years. Ethical approval for the InCHIANTI study was provided by 
the Italian National Research Council on Aging Ethical Committee, and participants gave 
informed consent.22
Outcome measures
At recruitment and at each three-yearly follow up, cognitive function was assessed by 
administration of the 30-point Mini Mental State Examination (MMSE); executive 
functioning was assessed using Trail-Making Tests A and B with a 300 second time limit.23 24 
We used the latest follow up data before censorship to examine changes in cognitive 
measures from baseline, adjusting for length of follow up. 
We defined substantial cognitive decline for each test as follows: a reduction in MMSE score 
of 5 points or more from baseline, being in the worst 10% of decliners from baseline in Trails 
A or Trails B, or failure to complete these tests in the time allowed.25-27 We also examined a 
composite outcome, based on the method of Espeland et al, whereby cognitive decline was 
defined by any one of the substantial cognitive decline criteria for the MMSE, Trails A or 
Trails B described above.28
During the recruitment medical examination blood pressure was measured with subjects 
resting supine using a standard mercury sphygmomanometer. The sequence of 
measurements was right arm first then, after a two minute pause, the left arm. Two further 
measurements subsequently took place on the higher reading arm. Inter-arm difference was 
calculated as right minus left from the paired first measurements. Systolic and diastolic 
blood pressures were defined as the mean of the second and third measurements. All blood 
pressure measurements were taken from the initial baseline recruitment examinations.
Statistical analysis
We planned a priori to adjust analyses for covariates known to be associated with vascular 
disease, IAD or cognitive decline. Specifically, these were: age, sex, baseline MMSE score, 
years of education, systolic and diastolic blood pressure, hypercholesterolemia (defined as 
total cholesterol 5.0 or greater), current smoking status, diabetes (defined as any of: 
recorded medical history of diabetes, use of medication for diabetes, or fasting glucose of 
7.0mmol/l at baseline), established vascular disease (defined as medical history of 
myocardial infarction, angina or peripheral arterial disease at baseline; ankle-brachial 
pressure index <0.9, or carotid artery stenosis of greater than 40% on clinical assessment), 
cerebrovascular disease (defined as medical history or clinical examination suggestive of 
previous stroke or transient ischaemic attack), body mass index (BMI) and length of time in 
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study.  
Continuous and discrete variables were compared according to IAD using t-tests and chi-
square tests as appropriate. Non-normally distributed continuous data were compared 
using Mann-Whitney U tests. We compared changes of cognitive test scores, and (to adjust 
for varied follow up lengths) rates of change of cognitive scores by dichotomous systolic IAD 
cut-offs. We then explored univariable and multivariable associations of absolute systolic 
IAD as both a continuous variable, and as a dichotomous variable, with substantial cognitive 
decline using logistic regression modelling. For dichotomous IAD we adopted IAD cut-offs of 
≥5 and ≥10 mmHg throughout for consistency with existing literature.29 Examination of the 
commonly quoted IAD ≥15mmHg threshold was planned a priori but is not presented due to 
a low prevalence of participants meeting this magnitude of IAD.
We calculated unadjusted odds ratios (OR) of substantial cognitive decline for each cognitive 
test separately and for the composite measure according to IAD. We explored multivariable 
associations of systolic IAD, adjusting for the covariates listed above with cognitive 
measures that showed significant univariable association with systolic IAD using backwards 
stepwise regression. The threshold for inclusion of covariates in multivariable modelling was 
set at P < 0.2. The final adjusted model was used to derive adjusted ORs for cognitive 
decline according to IAD. Terms for age, sex and systolic blood pressure were retained, 
irrespective of p-value, on aetiological grounds.
P-values were two-sided throughout. All analyses were performed using Stata Version 14 
(StataCorp, College Station, Texas, USA). 
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Results
There are 1453 participants in the InCHIANTI study cohort. After excluding participants 
missing blood pressure measurements, and those with a pre-existing diagnosis of dementia, 
there were 1251 eligible for analysis. Of these 118 lacked any follow-up data for cognitive 
tests, therefore all analyses were based on the remaining 1,133 participants (Figure 1). 
Median follow up was 9.0 years (inter-quartile range 8.2 to 9.2 years). Within the cohort 
follow up measurements existed for MMSE in 1,118 (98.7%), Trails A in 933 (82.3%) and 
Trails B in 657 (58.0%) participants. Those without follow up records, in comparison to those 
contributing to the analyses were older, had higher rates of vascular and cerebrovascular 
disease, and had lower baseline MMSE scores and years of completed education than 
participants included in the analyses (Table 1). 
Mean systolic blood pressure at recruitment was 145.6mmHg (SD 21.4) with evidence of 
rounding to zero (Figure 2). Within this population there were 277 (24.5%) people with a 
systolic IAD ≥ 5mmHg, 212 (18.7 %) with an IAD ≥ 10mmHg and 30 (2.7%) with an IAD ≥ 
15mmHg. Compared to those with an IAD < 10mmHg, those above the threshold had lower 
baseline scores for MMSE and longer Trails A and B times; they were older and completed 
shorter years of follow up. Blood pressures and the rate of hypertension were higher in 
association with an IAD (Table 2). 
MMSE scores declined at a greater rate for participants with a systolic IAD ≥ 5mmHg and      
≥ 10mmHg compared to those without. No differences were seen for the Trail Making Tests 
(Table 3).
On univariable analysis systolic IAD, as a continuous variable, was associated with the 
composite outcome (OR 1.16 per 5 mmHg of IAD (95%CI 1.02 to 1.31); P = 0.021). Using 
dichotomised terms for systolic IAD the odds of substantial decline in the MMSE score were 
greater with a systolic IAD ≥5mmHg (1.41 (95%CI 1.03 to 1.93); P = 0.032), and in the 
composite score with a systolic IAD ≥5mmHg or IAD ≥10mmHg (1.44 (95%CI 1.10 to 1.89); P 
= 0.009 and 1.39 (95%CI 1.03 to 1.88); P = 0.030). No difference was evident for Trail Making 
Tests (Table 4). 
Given no findings of univariable associations between Trail Making Tests and IAD, 
multivariable modelling was only undertaken to explore substantial decline in MMSE scores 
and in the composite scores. We derived multivariable models, to which IAD was added to 
calculate adjusted ORs for associations of IAD with cognitive measures. Variables retaining 
significance in either model were age, sex, baseline MMSE, years in education, diabetes, 
previous cerebrovascular event and duration of follow up (Table 5).  These models, with 
inclusion of systolic blood pressure as planned, were used to adjust univariable associations 
of IAD for all variables (Table 4). After adjustment, continuous IAD was no longer associated 
with any of the outcomes. For dichotomous IAD cut-offs only an IAD ≥5mmHg remained 
associated with increased odds of decline in the composite outcome (OR 1.5 (1.1 to 2.0); P = 
0.03). 
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In this cohort, representative of the older Italian population, a systolic inter-arm difference 
≥5mmHg was observed to be associated with a decline of 5 or more points in the Mini 
Mental State Examination score over a median nine year follow up period. When a 
composite score also taking account of a decline in Trail Making Tests is considered, this 
association is also observed for an inter-arm difference ≥10mmHg, and as a continuous 
variable. After adjustment in a multivariable model, the composite outcome remains more 
likely to be achieved with an inter-arm difference ≥5mmHg.
Strengths and limitations
This study achieved high retention and follow up rates over almost a decade, allowing 
longitudinal study of clinically meaningful changes. The availability of a large number of 
baseline variables permitted robust adjustment of findings, although completion rates for 
follow up Trail testing were lower than the MMSE so may have constrained the ability to 
demonstrate changes in these outcomes. The MMSE examination also has limitations as a 
screening tool for cognitive impairment and dementia, therefore we used an accepted 
definition of significant change in scores.30 A sequential blood pressure measurement 
method can over-estimate IAD in comparison to a simultaneous method, and the pause 
between measurements may have augmented differences due to white coat effects.10 31 
There was also evidence of rounding of blood pressure readings, which can contribute to 
measurement error through digit preference.32 Nevertheless these limitations make the 
blood pressure readings analogous to routine clinical measurements, and the prognostic 
value of IAD derived from sequential measurements in other studies has not differed 
significantly from that of simultaneous measurements.8 13 To minimise the impact of test to 
test variability in cognitive assessments we adopted valid criteria for a substantial reduction 
in cognition over time, and adjusted outcomes for duration of follow up.25-27 The composite 
measure for cognitive decline has been reported from cross-sectional work,28 but to our 
knowledge, it has not previously been reported in prospective analyses such as presented 
here. 
The InCHIANTI cohort is representative of an older Italian population (excepting those aged 
over 90).33 Ethnic differences in the aetiology and prognostic importance of systolic IAD may 
exist,13 34 but this is uncertain.31 Consequently we are cautious of extrapolating these 
findings to other ethnic groups. We did not observe rising risks of cognitive decline with 
increasing magnitude of IAD. Previous individual studies and study-level meta-analyses have 
also failed to show a positive correlation between size of hazard ratios for prospective 
mortality outcomes and magnitude of IAD,8 12 although this has recently become evident in 
our current large (>57,000 records) individual participant data meta-analysis.13 The current 
study had few people (<3%) with a systolic IAD ≥ 15mmHg; it lacked power to explore IADs 
above the ≥ 10 mmHg threshold and the sample size available for this study was too small to 
demonstrate trends in risk according to level of IAD. The limitations in measurement 
technique discussed above could also have contributed to the differences in associations 
seen between 5mmHg and 10mmHg IAD cut-offs.
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In presenting analyses of four cognitive outcomes we recognise the risk of spurious 
associations being observed by chance alone. A conservative approach to interpretation, 
taking account of a Bonferroni correction, would apply a P-value of 0.0125 as an appropriate 
threshold for significance testing. Whilst none of our adjusted findings met this level of 
significance, all of the odds ratios presented are consistent in direction (i.e. > 1.0) suggesting 
that IAD may be associated with cognitive decline, but that this study was limited in power 
(as evidenced by the wide confidence intervals observed) to demonstrate such associations. 
Due to limitations of the data we could take account of introduction of drugs for dementia 
during the study, however only 1% of the cohort reported use of such drugs at follow up, 
indicating a low likelihood of impact on our findings. 
Comparison with existing literature 
Systolic IADs have been observed to be associated in both cross-sectional and prospective 
studies with higher incidences of all-cause mortality, stroke and cerebral arterial stenoses.8 
35-37 An increasing pulse pressure is also associated with both magnitude of IAD and 
magnetic resonance imaging evidence of markers for dementia risk.9 34 38 Therefore an 
association of IAD with cognitive decline is plausible given these vascular associations, due 
to vascular stiffening.4 39  However, to our knowledge, only one previous longitudinal cohort 
study has examined this. Using data from the Framingham Heart Study, investigators found 
an association of IAD with cognitive decline restricted to the subgroup of participants 
possessing the APOE ε4 allele.21 One other study has reported an association between 
differences in ankle artery pressures and greater decline in a composite cognitive score in 
people with diabetes.28 Consequently, we believe that this study presents the first data to 
associate an IAD in blood pressure with cognitive decline in a general cohort representative 
of an older age community population. 
Given the absence of effective treatments to date for established dementia, current 
emphasis is on prevention and reduction of cognitive decline.19 Intensive blood pressure 
lowering may be effective but is not risk free strategy, therefore recognition of novel 
cardiovascular risk markers to refine risk prediction and stratify treatment priorities is 
important.40 IAD is one such easily measured risk marker, associated with arterial stiffening 
and elevated pulse wave velocity thus indicating increased risk of target organ damage at an 
early stage.41 Addition of non-invasive assessments of target organ damage can reclassify 
individuals with such risk markers present into higher risk groups.42 Our findings require 
confirmation in other populations but, if reproducible, then IAD measurement may offer an 
opportunity to identify, at a pre-clinical stage, those most likely to benefit from aggressive 
preventative strategies.20
Implications for research and/or practice 
Recommendations to initially check blood pressure in both arms are included in 
international hypertension guidelines.43 44 Uptake of bilateral measurement may be 
increasing, and this can be facilitated by providing clinicians with evidence about the 
implications of an IAD.45 46 The new National Institute for Health and Care Excellence 
hypertension guidelines have reduced their suggested threshold for a significant IAD from 
20mmHg to 15mmHg.44 More recent evidence suggests that a systolic IAD below 5mmHg 
can be considered a normal finding, whilst excess cardiovascular events and deaths start to 
be observed above this threshold.13 47-49 Our current findings provide initial evidence to add 
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cognitive decline to these outcomes at the same threshold, whilst evidence suggests that 
people with an IAD below 5 mmHg can be reassured. Awareness of the evidence around IAD 
can inform discussion of individual interventions to address modifiable risk factors and 
improve primary prevention of cardiovascular diseases. An inter-arm difference is easily 
checked without additional equipment or skills. Whilst simultaneous measurement might be 
preferred by guidelines, there is substantial evidence to demonstrate the prognostic 
associations of sequentially measured IADs obtained in practice.13 43
Intensive blood pressure lowering may reduce progression of cognitive impairment, but it is 
not without risk.19 Such regimes are consistently associated with more frequent adverse 
events such as acute kidney injury, hypotension, falls and fractures.50-53 Thus there is a 
trade-off between reducing risks of events and increasing risks of adverse events; this 
implies the need to personalise treatments by addressing risk markers for individuals.54 
Confirmation of IAD as a risk marker for future cognitive decline could help to target 
intensification of treatment to those most at risk of events.
Conclusions 
Among older adults, our findings suggest that a systolic inter-arm difference may be 
associated with global cognitive decline. Adjustment for cardiovascular risk markers 
attenuates but does not abolish this association. The current findings lacked power due to 
sample size limitations, but suggest that further study in bigger populations is warranted. 
Given that inter-arm differences in blood pressure are easily measured, confirmation of the 
findings reported here could, in future, inform individualised treatment to reduce the risk of 
cognitive decline and dementia.
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Legends of tables & figure
Table 1. Differences between eligible participants with and without follow-up data 
Table 2. Characteristics of participants according to systolic inter-arm difference by IAD 
status ≥ 10 or < 10 mmHg
Table 3. Changes in cognitive scores according to systolic inter-arm difference 
Table 4. Unadjusted and adjusted odds ratios for substantial cognitive decline for all 
participants according to systolic inter-arm difference
Table 5. Multivariable models for measures of cognitive decline associated with inter-arm 
difference
Figure 1 – Identification of participants eligible for study
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Age (years) 66.4 (15.3) 78.2 (11.7) <0.001
Female - n (%) 621 (54.8) 64 (52.2) 0.905
Current smokers – n (%) 218 (19.2) 17 (14.4) 0.201
Body mass index 27.2 (4.1) 27.5 (4.3) 0.478
Baseline MMSE score* 26.3 (2.9) 23.2 (4.2) <0.001
Years in education* 6.8 (4.2) 5.0 (3.3) <0.001
Years of follow up 8.1 (1.5) 2.9 (2.5) <0.001
Systolic blood pressure 145.6 (21.4) 152.2 (23.7) 0.002
Diastolic blood pressure 83.1 (9.5) 83.9 (9.3) 0.345
Systolic IAD ≥ 10 mmHg 2.4 (4.8) 2.7 (7.8) 0.564
Hypertension - n (%) 834 (73.6) 94 (79.7) 0.153
Diabetes – n (%) 143 (12.6) 15 (12.7) 0.978
Vascular disease - n (%) 177 (15.6) 36 (31.0) <0.001
Cerebrovascular disease - n (%) 49 (4.3) 18 (15.3) <0.001
Continuous data reported as mean (standard deviation), except when *non-normally distributed where 
median (interquartile range given)
MMSE = Mini mental state examination
IAD = inter-arm blood pressure difference
Table 1. Differences between eligible participants with and without 
follow-up data 
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IAD ≥ 10 mmHg
(212)
IAD < 10 mmHg
(921)
p-value
Age (years) 69.3 (12.9) 65.7 (15.7) 0.003
Female - n (%) 117 (55.2) 95 (44.8) 0.902
Current smokers – n (%) 38 (17.9) 180 (19.5) 0.590
Body mass index 26.8 (16.2) 27.2 (27.0) 0.210
Baseline MMSE score* 26 (24 to 28) 27 (25 to 29) 0.025
Baseline Trails A score* 76 (46 to 118) 65 (41 to 102) 0.003
Baseline Trails B score* 157 (98 to 246) 138 (84 to 227) 0.026
Years in education* 5 (4 to 8) 5 (5 to 8) 0.167
Years of follow up 7.8 (7.6) 8.2 (8.1) 0.006
Systolic blood pressure 158.2 (20.9) 142.6 (20.5) <0.001
Diastolic blood pressure 87.0 (9.0) 82.1 (9.3) <0.001
Hypertension - n (%) 187 (88.2) 647 (70.3) <0.001
Diabetes – n (%) 31 (14.6) 112 (12.2) 0.330
Vascular disease - n (%) 30 (14.2) 147 (16.0) 0.513
Cerebrovascular disease - n (%) 11 (5.2) 38 (4.1) 0.493
Continuous data reported as mean (standard dev ation), except when *non-normally distributed where 
median (interquartile range given)
MMSE = Mini mental state examination; IAD = systolic inter-arm difference
Table 2. Characteristics of participants according to systolic inter-arm 
difference by IAD status ≥ 10 or < 10 mmHg
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MMSE = Mini Mental State Examination; Trails = trail making score; IAD = systolic inter-arm difference
*change in unit score per year of follow up
Table 3. Changes in cognitive scores according to systolic inter-arm difference
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MMSE = Mini Mental State Examination; Trails = trail making score; IAD = systolic inter-arm difference
*adjusted for age, sex, baseline MMSE score, years in education, systolic blood pressure, ankle-brachial index, presence of diabetes, 
previous cerebrovascular event and duration of follow up
Table 4. Unadjusted and adjusted odds ratios for substantial cognitive decline for all participants according 
to systolic inter-arm difference
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Variable Decline in MMSE score ≥5 Composite outcome
OR P OR p
Age 1.09 <0.001 1.07 <0.001
Sex 1.20 0.267 1.35 0.037
Baseline MMSE 1.02 0.617 0.94 0.050
Years in education 0.91 0.003 0.90 <0.001
Systolic blood 
pressure
1.01 0.235 1.00 0.980
Ankle-brachial index 1.58 0.397 0.52 0.184
Diabetes 1.49 0.068 1.96 0.002
Previous 
cerebrovascular event
2.22 0.020 1.53 0.231
Duration of follow up 1.02 <0.001 1.02 <0.001
MMSE = Mini Mental State Examination
Variables dropped from models on backwards stepwise regression:
baseline cardiovascular disease; baseline diastolic blood pressure; hypercholesterolaemia
smoking status; body mass index; carotid stenosis ≥40%
Table 5. Multivariable models used to adjust associations of 
cognitive decline measures with inter-arm difference. 
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IAD = systolic inter-arm blood pressure difference
Figure 1 – Identification of participants eligible for study
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Figure 2 – distribution of systolic blood pressure at recruitment
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